Penbutolol contraindications

Revision as of 21:56, 4 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Penbutolol}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== levatol® is contraindicated in patients with cardiogenic shock, sinus bradycardia, second and third...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Penbutolol
LEVATOL ® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Penbutolol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

levatol® is contraindicated in patients with cardiogenic shock, sinus bradycardia, second and third degree atrioventricular conduction block, bronchial asthma, and those with known hypersensitivity to this product (see WARNINGS).[1]


References

  1. "LEVATOL (PENBUTOLOL SULFATE) TABLET [ACTIENT PHARMACEUTICALS, LLC]". Retrieved 4 February 2014.

Template:WikiDoc Sources